---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-012084"
form_type: "8-K"
ticker: "AZTR"
cik: "0001701478"
company_name: "Azitra, Inc."
filed_at: "2026-03-23T23:59:59+00:00"
generated_at: "2026-05-15T09:22:38.103280+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Azitra raises $10.5M initial PIPE, up to $31.4M with warrants, for cosmetic protein program

## Summary
- Initial gross proceeds of ~$10.5M from sale of Series A preferred & warrants; potential additional ~$20.9M if warrants exercised.
- Warrants exercisable at $0.123/share; Series B warrants expire 18 months after stockholder approval; Series C upon data announcement.
- Proceeds to fund R&D for filaggrin protein/peptide cosmetic program targeting $2.3B market growing to $3.7B by 2030.
- Insiders including CEO participated; Stonepine Capital and Nantahala Capital among investors.
- Company must seek stockholder approval for conversion of preferred shares into common; registration rights agreement filed.

## SEC filing metadata
- accession: 0001493152-26-012084
- form_type: 8-K
- ticker: AZTR
- cik: 0001701478
- company_name: Azitra, Inc.
- filed_at: 2026-03-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1701478/000149315226012084/0001493152-26-012084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1701478/000149315226012084/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-012084
- JSON: https://secwatch.observer/filing/0001493152-26-012084.json
- Plain text: https://secwatch.observer/filing/0001493152-26-012084.txt

## Source-grounded claims
- claim_id: f543c5a06f1db56e778740471d75d8e01d3b48e1
  claim: Azitra, Inc.: Filed Certificate of Designations for Series A Preferred Stock (effective 2026-03-19).
  evidence_excerpt: On March 19, 2026 (the “Filing Date”), the Company filed the Certificate of Designations with the Secretary of State of the State of Delaware designating 12,000 shares of its authorized and unissued preferred stock as Series A Preferred Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1701478/000149315226012084/0001493152-26-012084-index.htm
- claim_id: 72d5b62843d6f333748f76552f321be688a0797b
  claim: Azitra, Inc. entered into Securities Purchase Agreement with the purchasers named therein valued at gross proceeds of up to approximately $31.4 million (effective 2026-03-18).
  evidence_excerpt: On March 18, 2026, Azitra, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell an aggregate of (i) 10,485 shares of its Series A convertible non-redeemable preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”), (ii) Series B warrants (the “Series B Warrants”) to purchase up to 85,233,126 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (or, in certain circumstances, pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”)), (iii) Series C warrants to purchase up to 85,233,126 shares of Common Stock (or, in certain circumstances, Pre-Funded Warrants) (the “Series C Warrants” and, together with the Series B Warrants, the “Warrants”) to the Purchasers in a private placement (the “PIPE Financing”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1701478/000149315226012084/0001493152-26-012084-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.